Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2018 Aug 8;27(11):1352–1357. doi: 10.1158/1055-9965.EPI-18-0448

Table 4:

HBsAg Screening Indications for Asian and Pacific Islanders in UC Davis Health System, January 2016–January 2017

HBsAg EMR Alert Control P-value
HBsAg ordered N=119 (%) N=48 (%) .005
Asymptomatic 99 (83.2%) 28 (58.3%)
Abnormal Liver Test 7(5.9%) 9 (18.8%)
Prenatal Screening 11 (9.2%) 9 (18.8%)
Known CHB infection 2 (1.7%) 2 (4.2%)

HBsAg: Hepatitis B surface antigen

CHB: Chronic hepatitis B